Mr. Robert M. Davis is CFO & Executive Vice President-Global Services at Merck & Co., Inc. and Chairman at Gambro AB.
He is on the Board of Directors at C.R. Bard, Inc. (New Jersey), AdvaMedDx and Rush University Medical Center. Mr. Davis was previously employed as Chief Financial Officer & Vice President by Baxter Healthcare Corp., VP & President-Medical Products Business by Baxter International, Inc., and Director-Corporate Financial Planning by Eli Lilly & Co.
He received his undergraduate degree from Miami University, a graduate degree from Northwestern University School of Law and an MBA from Kellogg School of Management.